Stockreport

Lucy Scientific to Acquire SANA-013 Psychedelic Assets from Drug Developer Wesana Health

Lucy Scientific Discovery Inc.  (LSDI) 
PDF Transaction subject to Wesana shareholder approval and expected to close in Q2 2023SANA-013 combination of psilocybin and CBD being developed for potential treatment of [Read more]